{"id":"https://openalex.org/W2991537666","doi":"https://doi.org/10.1183/13993003.congress-2019.oa4950","title":"High Efficacy of High-dose Nitric Oxide and its Synergistic Effect with Antibiotics against Mycobacterium Abscessus","display_name":"High Efficacy of High-dose Nitric Oxide and its Synergistic Effect with Antibiotics against Mycobacterium Abscessus","publication_year":2019,"publication_date":"2019-09-28","ids":{"openalex":"https://openalex.org/W2991537666","doi":"https://doi.org/10.1183/13993003.congress-2019.oa4950","mag":"2991537666"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2019.oa4950","doi":"https://doi.org/10.1183/13993003.congress-2019.oa4950","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2019.oa4950","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory infections","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050838545","display_name":"Trisha Chau","orcid":"https://orcid.org/0000-0001-8662-3142","observed_orcids":["https://orcid.org/0000-0001-8662-3142"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trisha Chau","raw_affiliation_strings":["Pulmonary Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, United States of America","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046223432","display_name":"Kelvin Blade","orcid":"https://orcid.org/0000-0003-3387-6693","observed_orcids":["https://orcid.org/0000-0003-3387-6693"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelvin Blade","raw_affiliation_strings":["Pulmonary Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, United States of America","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018521451","display_name":"Juas Da Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juas Da Silva","raw_affiliation_strings":["Pulmonary Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, United States of America","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019769567","display_name":"Abdi Ghaffari","orcid":"https://orcid.org/0000-0002-5035-243X","observed_orcids":["https://orcid.org/0000-0002-5035-243X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdi Ghaffari","raw_affiliation_strings":["AIT Therapeutics, Garden City, NY, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AIT Therapeutics, Garden City, NY, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016895895","display_name":"Adrian M. Zelazny","orcid":"https://orcid.org/0000-0003-2847-7428","observed_orcids":["https://orcid.org/0000-0003-2847-7428"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adrian Zelazny","raw_affiliation_strings":["Department of Laboratory Medicine, National Institute of Health, Bethesda, MD, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, National Institute of Health, Bethesda, MD, United States of America","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113147167","display_name":"Kenneth N. Olivier","orcid":"https://orcid.org/0000-0001-8200-255X","observed_orcids":["https://orcid.org/0000-0001-8200-255X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Olivier","raw_affiliation_strings":["Pulmonary Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, United States of America","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"OA4950","last_page":"OA4950"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11316","display_name":"Mycobacterium research and diagnosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11316","display_name":"Mycobacterium research and diagnosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12824","display_name":"Infections and bacterial resistance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mycobacterium-abscessus","display_name":"Mycobacterium abscessus","score":0.9879999756813049},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.9459999799728394},{"id":"https://openalex.org/keywords/amikacin","display_name":"amikacin","score":0.7860000133514404},{"id":"https://openalex.org/keywords/clofazimine","display_name":"clofazimine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antibiotic-synergy","display_name":"antibiotic synergy","score":0.75},{"id":"https://openalex.org/keywords/nontuberculous-mycobacteria","display_name":"nontuberculous mycobacteria","score":0.9369999766349792},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.7639999985694885},{"id":"https://openalex.org/keywords/minimum-inhibitory-concentration","display_name":"minimum inhibitory concentration","score":0.9039999842643738},{"id":"https://openalex.org/keywords/pulmonary-infection","display_name":"pulmonary infection","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C2776297342","wikidata":"https://www.wikidata.org/wiki/Q418611","display_name":"Clofazimine","level":3,"score":0.9695791006088257},{"id":"https://openalex.org/C2776111603","wikidata":"https://www.wikidata.org/wiki/Q6946978","display_name":"Mycobacterium abscessus","level":4,"score":0.9502934217453003},{"id":"https://openalex.org/C2777427914","wikidata":"https://www.wikidata.org/wiki/Q408529","display_name":"Amikacin","level":3,"score":0.8859851956367493},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7282792329788208},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.622261643409729},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.5561893582344055},{"id":"https://openalex.org/C2776962512","wikidata":"https://www.wikidata.org/wiki/Q118551","display_name":"Clarithromycin","level":3,"score":0.5035099387168884},{"id":"https://openalex.org/C176947019","wikidata":"https://www.wikidata.org/wiki/Q597889","display_name":"Minimum inhibitory concentration","level":3,"score":0.44952714443206787},{"id":"https://openalex.org/C2780374374","wikidata":"https://www.wikidata.org/wiki/Q194309","display_name":"Mycobacterium","level":3,"score":0.43595078587532043},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34253740310668945},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.25871995091438293},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25306037068367004},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15603366494178772},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1250622272491455},{"id":"https://openalex.org/C2780695269","wikidata":"https://www.wikidata.org/wiki/Q36956","display_name":"Leprosy","level":2,"score":0.10297256708145142}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2019.oa4950","doi":"https://doi.org/10.1183/13993003.congress-2019.oa4950","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2019.oa4950","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory infections","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7213230050","https://openalex.org/W2905770087","https://openalex.org/W3048102104","https://openalex.org/W3208945936","https://openalex.org/W2970283504","https://openalex.org/W2159254579","https://openalex.org/W7098045141","https://openalex.org/W2327728134","https://openalex.org/W4382133730","https://openalex.org/W4390744089"],"abstract_inverted_index":{"Mycobacterium":[0,52],"abscessus":[1,35,74,110,170,218,233],"(M.":[2],"abscessus)":[3],"is":[4,228],"an":[5,189],"emerging":[6],"multi-drug":[7],"resistant":[8],"non-tuberculous":[9],"mycobacterium":[10],"(NTM)":[11],"with":[12,17,89,125,156,183,212,236],"increasing":[13],"prevalence":[14],"in":[15,36,59,69,168,181,188,193,210,215],"patients":[16],"underlying":[18],"lung":[19,55,75],"disease.":[20],"We":[21,96],"have":[22,97],"demonstrated":[23,162],"that":[24,179,225],"high-dose":[25,86],"nitric":[26],"oxide":[27],"(NO)":[28],"shows":[29],"potent":[30],"antibacterial":[31],"activity":[32],"against":[33,93,231],"M.":[34,73,94,109,169,217,232],"vitro.":[37],"Arikayce\u00ae":[38],"(amikacin":[39],"liposome":[40],"inhalation)":[41],"was":[42,134],"recently":[43],"approved":[44],"by":[45,147],"FDA":[46],"for":[47,143,160],"the":[48,70,82,105,138,204],"treatment":[49,60,71],"of":[50,61,72,85,107,206],"refractory":[51],"avium":[53],"complex":[54],"infection.":[56,76],"Clofazimine,":[57],"used":[58,98,135],"leprosy":[62],"and":[63,91,115,117,122,127,173,199,208,234],"tuberculosis,":[64],"has":[65],"been":[66],"increasingly":[67],"utilized":[68],"In":[77],"this":[78],"study,":[79],"we":[80],"investigated":[81],"synergistic":[83,153],"effect":[84],"NO":[87,100,121,158,180,198,214,227],"combined":[88],"amikacin":[90,209],"clofazimine":[92,126,184,207,237],"abscessus.":[95],"a":[99,163],"Exposure":[101],"Chamber":[102],"to":[103,120,136,151,165,197],"test":[104],"susceptibility":[106],"three":[108],"clinical":[111,171],"strains":[112,172,219],"(MAB-062600,":[113],"MAB-030804,":[114],"MAB-010708)":[116],"ATCC":[118,174],"19977":[119],"its":[123,241],"combination":[124,182,211,235],"amikacin.":[128],"Disc":[129],"Diffusion":[130],"or":[131],"E-test":[132],"methods":[133],"determine":[137,152],"minimum":[139],"inhibitory":[140],"concentrations":[141],"(MICs)":[142],"each":[144],"strain":[145,195],"followed":[146],"Agar":[148],"Dilution":[149],"method":[150],"effects.":[154],"Treatment":[155],"250ppm":[157,213,226],"alone":[159],"10hr":[161],"5-":[164],"6-log":[166],"reductions":[167],"19977.":[175],"Preliminary":[176],"results":[177,187],"indicate":[178],"(2X":[185],"MIC)":[186],"additional":[190],"1-log":[191],"reduction":[192],"MAB-062600":[194],"compared":[196],"CLO":[200],"alone.":[201],"Tests":[202],"on":[203],"effects":[205],"remaining":[216],"are":[220],"ongoing.":[221],"Our":[222],"findings":[223],"suggests":[224],"highly":[229],"efficacious":[230],"may":[238],"further":[239],"improve":[240],"activity.":[242]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2019-12-05T00:00:00"}